デフォルト表紙
市場調査レポート
商品コード
1429657

幹細胞療法の世界市場レポート 2024

Stem Cell Therapy Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
幹細胞療法の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

幹細胞療法の市場規模は、今後数年間で急速に成長すると予想されています。 2028年には13.4%の年間複合成長率(CAGR)で131億2,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、政府支援の増加、高齢化人口の急速な増加、研究開発支出の増加、ヘルスケア支出の継続的な増加に起因する可能性があります。この期間に予想される主な動向には、間葉系 幹細胞療法の進歩を注意深く監視し、この分野のイノベーションを活用することに重点が置かれています。市場関係者は、製品のイノベーションを推進し、収益を促進するために、コラボレーションや買収に取り組むことをお勧めします。さらに、企業は患者治療のための人工多能性幹細胞(iPSC)由来のナチュラルキラー(NK)細胞の開発への投資を検討する必要があります。 幹細胞療法市場では、特にがんに対する治療法の開発に戦略的に重点を置くことで、体細胞の競合他社に対する競争力を高めることができます。最後に、幹細胞療法市場の企業は、人工知能を活用して製品の品質、安全性、製造の生産性を向上させることが奨励されています。

幹細胞療法市場の成長は、慢性疾患の有病率の増加に大きく影響されます。労働時間の延長、身体活動の制限、不健康な食生活などの要因が慢性疾患の発生率の増加に寄与しており、幹細胞療法の需要が生じています。国連の記事によると、2030年までに世界の死亡者数の70%が慢性疾患によるものになると予測されています。世界の慢性疾患の負担は約60%に達すると予想されており、幹細胞療法市場の成長がさらに加速します。

拡大する個別化医療分野は、幹細胞療法市場の将来の成長を推進する態勢が整っています。精密医療としても知られる個別化医療には、遺伝子、環境、ライフスタイルの個人差を考慮して治療計画を調整することが含まれます。このアプローチは、個々の患者の固有の遺伝的および医学的プロファイルに基づいて幹細胞治療をカスタマイズすることにより、幹細胞治療の有効性を高めます。これにより、治療結果が改善されるだけでなく、副作用も軽減され、患者の健康が優先されます。個別化医療の患者中心の性質は、正確な患者の選択、より効果的な臨床試験、市場の拡大と相まって、幹細胞治療の魅力の増大に貢献し、市場の成長を促進すると期待されています。たとえば、2022年に食品医薬品局の医薬品評価研究センター(CDER)は37の新しい分子実体(NME)を承認し、その約34%(そのうち12個)は個別化医療連合(PMC)によって個別化医療として分類されました。したがって、個別化医療の注目度の高まりが、幹細胞療法市場の拡大の重要な推進力となります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年~2023年
  • 世界の市場規模予測と成長、2023年~2028年、2033年

第6章 市場セグメンテーション

  • 世界の幹細胞治療市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 同種幹細胞療法
  • 自家幹細胞療法
  • 世界の幹細胞治療市場、細胞由来別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 成人幹細胞
  • 人工多能性幹細胞
  • 胚性幹細胞
  • 世界の幹細胞治療市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 筋骨格系疾患
  • 創傷と怪我
  • がん
  • 自己免疫疾患
  • その他の用途
  • 世界の幹細胞治療市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • クリニック
  • 研究センター
  • その他

第7章 地域および国の分析

  • 世界の幹細胞療法市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の幹細胞治療市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 幹細胞療法市場の競合情勢
  • 幹細胞療法市場の企業プロファイル
    • Smith &Nephew Plc
    • Fujifilm Holding Corporation
    • Thermo Fisher Scientific Inc
    • Takara Bio Inc
    • MEDIPOST Co., Ltd.

第31章 その他の大手および革新的な企業

  • Astellas Pharma Inc.
  • Catalent, Inc.
  • Pharmicell Co., Ltd.
  • JCR Pharmaceuticals Co., Ltd.
  • Stemedica Cell Technologies, Inc.
  • Pluristem Technologies Ltd
  • Becton Dickinson Private Limited
  • Stem Cell Technologies India Pvt. Ltd
  • Cordlife India Pvt. Ltd
  • Lifecell International Pvt. Ltd
  • Stemcyte India Therapeutics Private Limited
  • Stempeutics Research Private Limited
  • Reelabs Private Limited
  • Anterogen Co., Ltd
  • Tonghua Dongbao Pharmaceutical Co

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r14628

Stem cell therapy is a branch of regenerative medicine that harnesses the power of stem cells or their derivatives to prompt the body's natural repair processes in damaged, malfunctioning, or injured tissues. It represents a significant advancement beyond organ transplantation, offering a viable alternative to scarce donor organs.

There are two primary types of stem cell therapy allogeneic stem cell therapy and autologous stem cell therapy. In allogeneic stem cell transplantation, stem cells are sourced from a healthy donor and transferred to the patient's body following intensive chemotherapy or radiation. The cells can be derived from various sources, including adult stem cells, induced pluripotent stem cells, and embryonic stem cells, and are employed in treating conditions such as musculoskeletal disorders, wounds and injuries, cancer, autoimmune disorders, among others. These therapies find application in hospitals and clinics.

The stem cell therapy market research report is one of a series of new reports from The Business Research Company that provides stem cell therapy market statistics, including stem cell therapy industry global market size, regional shares, competitors with a stem cell therapy market share, detailed stem cell therapy market segments, market trends and opportunities, and any further data you may need to thrive in the stem cell therapy industry. This stem cell therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The stem cell therapy market size has grown exponentially in recent years. It will grow from $6.43 billion in 2023 to $7.94 billion in 2024 at a compound annual growth rate (CAGR) of 23.5%. The historical period's growth can be ascribed to an increasing prevalence of chronic diseases, heightened funding from both governmental and private entities, rapid expansion in emerging markets, augmented investments in cell and gene therapies, a surge in healthcare expenditure, and a rise in pharmaceutical research and development expenditure.

The stem cell therapy market size is expected to see rapid growth in the next few years. It will grow to $13.12 billion in 2028 at a compound annual growth rate (CAGR) of 13.4%. The anticipated growth in the forecast period can be attributed to an increase in government support, a rapid rise in the aging population, heightened research and development spending, and a continued increase in healthcare expenditure. Key trends expected in this period involve a focus on closely monitoring advancements in mesenchymal stem cell therapy to leverage innovations in the field. Market players are advised to engage in collaborations and acquisitions to advance product innovation and drive revenues. Furthermore, companies should consider investments in the development of induced pluripotent stem cell (iPSC)-derived natural killer (NK) cells for patient treatment. In the stem cell therapy market, a strategic emphasis on developing therapies, particularly for cancer, can provide a competitive edge over somatic cell competitors. Lastly, companies in the stem cell therapy market are encouraged to harness artificial intelligence to enhance product quality, safety, and manufacturing productivity.

The growth of the stem cell therapy market is significantly influenced by the increasing prevalence of chronic diseases. Factors such as extended working hours, limited physical activity, and unhealthy dietary habits contribute to the rising incidence of chronic diseases, creating a demand for stem cell therapy. According to a United Nations article, it is projected that by 2030, chronic diseases will account for 70% of global deaths. The global burden of chronic diseases is expected to reach approximately 60%, further fueling the growth of the stem cell therapy market.

The expanding field of personalized medicine is poised to drive the future growth of the stem cell therapy market. Personalized medicine, also known as precision medicine, involves tailoring medical treatment plans to account for individual variations in genes, environment, and lifestyle. This approach enhances the effectiveness of stem cell treatments by customizing them based on the unique genetic and medical profiles of individual patients. This not only improves treatment outcomes but also reduces adverse effects, prioritizing patient well-being. The patient-centric nature of personalized medicine, coupled with precise patient selection, more effective clinical trials, and market expansion, contributes to the increasing appeal of stem cell therapies and is expected to propel market growth. For instance, in 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), with approximately 34% (12 of them) classified as personalized medicines by the Personalized Medicine Coalition (PMC). Consequently, the growing prominence of personalized medicine is a key driver for the expansion of the stem cell therapy market.

Companies within the stem cell therapy market are increasingly engaging in strategic partnerships, representing mutually beneficial agreements between entities that do not directly compete. A notable example is the partnership formed in May 2022 between SQZ Biotechnologies, a US-based biotechnology company, and STEMCELL Technologies Inc., a Canada-based biotechnology company. This collaboration aims to develop and commercialize a research-use-only (RUO) microfluidic intracellular delivery system based on SQZ's Cell Squeeze technology. The partnership is geared towards providing the life sciences community with enhanced cell engineering capabilities for preclinical research. SQZ Biotechnologies and STEMCELL Technologies Inc. are expected to present significant findings demonstrating the potential of the RUO system in efficiently delivering cargoes to primary immune cell types, showcasing advancements in cell engineering with mRNA and CRISPR/Cas9 in hematopoietic stem cells.

Major players in the stem cell therapy market are directing their focus towards the development of innovative technologies, such as Induced Pluripotent Stem Cells (iPSC), to enhance the efficiency of stem cell therapies. iPSCs are derived from blood or skin cells that are reProgramd to an embryonic-such as pluripotent state, offering an unlimited source of various human cells crucial for stem cell therapeutic purposes. An example of this technology is the genome engineering platform for iPSCs launched by Synthego Corporation, a US-based genome engineering company, in October 2022. This platform provides an unprecedented level of editing efficiency for iPSCs on an industrial scale, facilitating precise modifications and creating disease models, including neurodegenerative conditions such as Alzheimer's disease. The platform enables the creation of high-quality, physiologically relevant biological models for translational medicine, promising advancements in research and therapeutic development.

In July 2022, Vertex Pharmaceuticals Inc., a US-based biotechnology company, made a significant acquisition by purchasing ViaCyte Pharma Inc. for $320 million. This acquisition strengthened Vertex Pharmaceuticals' commitment to developing transformative cell replacement therapies for type 1 diabetes. ViaCyte Pharma Inc., a US-based biotechnology company, focuses on innovative stem cell-derived cell replacement therapies, particularly for type 1 diabetes (T1D). The acquisition provided Vertex Pharmaceuticals with additional tools, technologies, stem cell lines, and manufacturing facilities, accelerating their ongoing programs in this field.

Major companies operating in the stem cell therapy market report are Smith & Nephew PLC, Fujifilm Holding Corporation, Thermo Fisher Scientific Inc., Takara Bio Inc., MEDIPOST Co., Ltd., Astellas Pharma Inc., Catalent, Inc., Pharmicell Co., Ltd., JCR Pharmaceuticals Co., Ltd., Stemedica Cell Technologies, Inc., Pluristem Technologies Ltd., Becton Dickinson Private Limited, Stem Cell Technologies India Pvt. Ltd., Cordlife India Pvt. Ltd., Lifecell International Pvt. Ltd., Stemcyte India Therapeutics Private Limited, Stempeutics Research Private Limited, Reelabs Private Limited, Anterogen Co., Ltd., Tonghua Dongbao Pharmaceutical Co, China Biologic Products Holdings Inc., Astrazenaca, Ablbio, Adimmune, Henlius, China Regenerative Medicine International, Innovent Biologics, Bio-Thera, Hisun Pharma, 3sbio, Beijing Shuanglu Pharmaceuticals, Qilu Pharmaceutical, Shanghai Fosun Pharmaceuticals , Cellerix, Cellgenix, Nsgene, Tigenix, Renuron Group, Smart Cells And Genenta Science, Amsterdam Molecular Therapeutics (Amt), Ark Therapeutics, Arthrogen Bv, Diamyd Medical Ab, Oxford Biomedica, Transgene, Mol Med, Selvita, Mabion, Pure Biologics, Oncoarendi Therapeutics, Captor Therapeutics, Celon Pharma, Nanovelos, Dickinson And Company, Sigma Aldrich (A Subsidiary Of Merck Kgaa), Osiris Therapeutics, Capricortherapeutics, Cellular Dynamics Discgenics, Takeda Pharmaceuticals, Kolon Tissue Gene, Athersys, Cyro-Cell International, Geron Corporation, Mesoblast Ltd., Astrom Biosciences Inc., Celgene Corporation, Invitrogen, Cytori Therapeutics Inc., Nuvasive Inc., Bristol-Myers Squibb Aldagen Inc., Caladrius Biosciences Inc., Adcock Ingram, Bayer East Africa Ltd., Biogen Sa, Daiichi Sankyo Co. Ltd., Gamida Cell Ltd., Gilead Sciences, Inc., Novartis Ag, Pfizer, Sanofi

North America was the largest region in the stem cell therapy market in 2023. The Middle East is expected to be the fastest-growing region in the global stem cell therapy market during the forecast period. The regions covered in the stem cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the stem cell therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The stem cell therapy market includes revenues earned by entities by hematopoietic stem cells, skin stem cells, neural stem cells, and mesenchymal stem cells. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Stem Cell Therapy Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on stem cell therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for stem cell therapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The stem cell therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Allogeneic Stem Cell Therapy; Autologous Stem Cell Therapy
  • 2) By Cell Source: Adult Stem Cells; Induced Pluripotent Stem Cells; Embryonic Stem Cells
  • 3) By Application: Musculoskeletal Disorders and Wounds & Injuries; Cancer; Autoimmune Disorders; Others
  • 4) By End-Users: Hospitals And Clinics; Research Centers; Others.
  • Companies Mentioned: Smith & Nephew Plc; Fujifilm Holding Corporation; Thermo Fisher Scientific Inc; Takara Bio Inc; MEDIPOST Co., Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Stem Cell Therapy Market Characteristics

3. Stem Cell Therapy Market Trends And Strategies

4. Stem Cell Therapy Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Stem Cell Therapy Market Size and Growth

  • 5.1. Global Stem Cell Therapy Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Stem Cell Therapy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Stem Cell Therapy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Stem Cell Therapy Market Segmentation

  • 6.1. Global Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Allogeneic Stem Cell Therapy
  • Autologous Stem Cell Therapy
  • 6.2. Global Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Adult Stem Cells
  • Induced Pluripotent Stem Cells
  • Embryonic Stem Cells
  • 6.3. Global Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Musculoskeletal Disorders
  • Wounds and Injuries
  • Cancer
  • Autoimmune Disorders
  • Other Applications
  • 6.4. Global Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Clinics
  • Research Centers
  • Others

7. Stem Cell Therapy Market Regional And Country Analysis

  • 7.1. Global Stem Cell Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Stem Cell Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Stem Cell Therapy Market

  • 8.1. Asia-Pacific Stem Cell Therapy Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Stem Cell Therapy Market

  • 9.1. China Stem Cell Therapy Market Overview
  • 9.2. China Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Stem Cell Therapy Market

  • 10.1. India Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Stem Cell Therapy Market

  • 11.1. Japan Stem Cell Therapy Market Overview
  • 11.2. Japan Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Stem Cell Therapy Market

  • 12.1. Australia Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Stem Cell Therapy Market

  • 13.1. Indonesia Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Stem Cell Therapy Market

  • 14.1. South Korea Stem Cell Therapy Market Overview
  • 14.2. South Korea Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Stem Cell Therapy Market

  • 15.1. Western Europe Stem Cell Therapy Market Overview
  • 15.2. Western Europe Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Stem Cell Therapy Market

  • 16.1. UK Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Stem Cell Therapy Market

  • 17.1. Germany Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Stem Cell Therapy Market

  • 18.1. France Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Stem Cell Therapy Market

  • 19.1. Italy Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Stem Cell Therapy Market

  • 20.1. Spain Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Stem Cell Therapy Market

  • 21.1. Eastern Europe Stem Cell Therapy Market Overview
  • 21.2. Eastern Europe Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Stem Cell Therapy Market

  • 22.1. Russia Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Stem Cell Therapy Market

  • 23.1. North America Stem Cell Therapy Market Overview
  • 23.2. North America Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Stem Cell Therapy Market

  • 24.1. USA Stem Cell Therapy Market Overview
  • 24.2. USA Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Stem Cell Therapy Market

  • 25.1. Canada Stem Cell Therapy Market Overview
  • 25.2. Canada Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Stem Cell Therapy Market

  • 26.1. South America Stem Cell Therapy Market Overview
  • 26.2. South America Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Stem Cell Therapy Market

  • 27.1. Brazil Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Stem Cell Therapy Market

  • 28.1. Middle East Stem Cell Therapy Market Overview
  • 28.2. Middle East Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Stem Cell Therapy Market

  • 29.1. Africa Stem Cell Therapy Market Overview
  • 29.2. Africa Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Stem Cell Therapy Market Competitive Landscape And Company Profiles

  • 30.1. Stem Cell Therapy Market Competitive Landscape
  • 30.2. Stem Cell Therapy Market Company Profiles
    • 30.2.1. Smith & Nephew Plc
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Fujifilm Holding Corporation
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Takara Bio Inc
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. MEDIPOST Co., Ltd.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Stem Cell Therapy Market Other Major And Innovative Companies

  • 31.1. Astellas Pharma Inc.
  • 31.2. Catalent, Inc.
  • 31.3. Pharmicell Co., Ltd.
  • 31.4. JCR Pharmaceuticals Co., Ltd.
  • 31.5. Stemedica Cell Technologies, Inc.
  • 31.6. Pluristem Technologies Ltd
  • 31.7. Becton Dickinson Private Limited
  • 31.8. Stem Cell Technologies India Pvt. Ltd
  • 31.9. Cordlife India Pvt. Ltd
  • 31.10. Lifecell International Pvt. Ltd
  • 31.11. Stemcyte India Therapeutics Private Limited
  • 31.12. Stempeutics Research Private Limited
  • 31.13. Reelabs Private Limited
  • 31.14. Anterogen Co., Ltd
  • 31.15. Tonghua Dongbao Pharmaceutical Co

32. Global Stem Cell Therapy Market Competitive Benchmarking

33. Global Stem Cell Therapy Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Stem Cell Therapy Market

35. Stem Cell Therapy Market Future Outlook and Potential Analysis

  • 35.1 Stem Cell Therapy Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Stem Cell Therapy Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Stem Cell Therapy Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer